Cargando…

A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses

The tremendous global impact of the current SARS-CoV-2 pandemic, as well as other current and recent outbreaks of (re)emerging viruses, emphasize the need for fast-track development of effective vaccines. Yellow fever virus 17D (YF17D) is a live-attenuated virus vaccine with an impressive efficacy r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oreshkova, Nadia, Myeni, Sebenzile K., Mishra, Niraj, Albulescu, Irina C., Dalebout, Tim J., Snijder, Eric J., Bredenbeek, Peter J., Dallmeier, Kai, Kikkert, Marjolein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704410/ https://www.ncbi.nlm.nih.gov/pubmed/34960238 http://dx.doi.org/10.3390/vaccines9121492

Ejemplares similares

Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase
por: Myeni, Sebenzile K., et al.
Publicado: (2023)

Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice
por: Ma, Ji, et al.
Publicado: (2021)

Limited evolution of the yellow fever virus 17d in a mouse infection model
por: Kum, Dieudonné Buh, et al.
Publicado: (2019)

A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice
por: Kum, Dieudonné Buh, et al.
Publicado: (2020)

Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression
por: Bailey-Elkin, Ben A., et al.
Publicado: (2014)

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies
por: Mishra, Niraj, et al.
Publicado: (2020)

Zika Virus Replicons for Drug Discovery
por: Xie, Xuping, et al.
Publicado: (2016)

SipB-SipC Complex Is Essential for Translocon Formation
por: Myeni, Sebenzile K., et al.
Publicado: (2013)

A High-Throughput Yellow Fever Neutralization Assay
por: Rasulova, Madina, et al.
Publicado: (2022)

17D Yellow Fever Virus Vaccine
por: Monath, Thomas P.
Publicado: (2013)

Arterivirus nsp2 Cysteine Proteinase
por: Kikkert, Marjolein, et al.
Publicado: (2013)

Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses
por: Rabouw, Huib H., et al.
Publicado: (2016)

Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
por: Nakamura, Akina, et al.
Publicado: (2022)

A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
por: Kum, Dieudonné B., et al.
Publicado: (2018)

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
por: Bos, Rinke, et al.
Publicado: (2020)

On Yellow-Fever
por: Sheppard, J. B.
Publicado: (1816)

Generation of a reporter yellow fever virus for high throughput antiviral assays
por: Sanchez-Velazquez, Ricardo, et al.
Publicado: (2020)

Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study
por: Roukens, Anna H., et al.
Publicado: (2011)

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge
por: Lemmens, Viktor, et al.
Publicado: (2023)

Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial
por: Roukens, Anna H., et al.
Publicado: (2008)

A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine
por: Yan, Kexin, et al.
Publicado: (2020)

The yellow fever of Ireland.
por: Logan, J. S.
Publicado: (1966)

The Yellow Fever Position
por: Russell, Alexander J. H.
Publicado: (1939)

The Yellow Fever Danger
por: Megaw, J. W. D.
Publicado: (1929)

Observations on the Yellow Fever
por: Dickson, D. J. H.
Publicado: (1808)

The Microbe of Yellow Fever
por: Gaston, J. McF.
Publicado: (1887)

Yellow Fever Inoculation
por: Gaston, J. McF.
Publicado: (1887)

The Yellow Fever Panic
por: LeHardy, J. C.
Publicado: (1888)

Yellow Fever Inoculation
por: Gaston, J. McF.
Publicado: (1893)

A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination
por: Wieten, Rosanne W., et al.
Publicado: (2016)

Host Factors in Coronavirus Replication
por: de Wilde, Adriaan H., et al.
Publicado: (2017)

Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective
por: Hansen, Clairissa A, et al.
Publicado: (2023)

Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease
por: van der Lubbe, Joan E. M., et al.
Publicado: (2021)

A Brucella effector modulates the Arf6‐Rab8a GTPase cascade to promote intravacuolar replication
por: Borghesan, Elizabeth, et al.
Publicado: (2021)

Yellow Fever
Publicado: (1898)

Yellow Fever
Publicado: (1901)

Yellow Fever
Publicado: (1900)

Yellow Fever
por: Finlay, Charles
Publicado: (1894)

Yellow Fever
por: Finlay, Charles
Publicado: (1894)

Yellow Fever
por: Finlay, Charles
Publicado: (1894)

Cannot write session to /tmp/vufind_sessions/sess_bh3aqr3fgklosirairm5dsqdm8